Heat Biologics, Inc.
HTBXAMEXHealthcare
$2.38
+$0.01(+0.42%)
Market Cap$61074370
P/E Ratio—
52W High$2.48
52W Low$2.33
Heat Biologics, Inc.（HTBX）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · HTBX · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($35.40M) | ($26.05M) | ($20.02M) | ($15.73M) | ($11.84M) |
| Depreciation & Amort. | $0.00M | $0.33M | $0.23M | $0.24M | $0.13M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Change in Working Capital | ($14.68M) | ($4.70M) | $2.65M | ($6.64M) | $5.06M |
| Net Cash from Operations | $0.00M | ($22.02M) | ($12.84M) | ($21.71M) | ($6.30M) |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | ($0.34M) | ($0.27M) | ($0.59M) | ($0.06M) |
| Purchases of Investments | $0.00M | ($105.93M) | ($0.14M) | ($5.57M) | $0.00M |
| Sales of Investments | $0.00M | $10.84M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | $0.00M | ($95.42M) | ($0.29M) | ($6.16M) | ($0.53M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $0.00M | $119.33M | $0.02M | $40.12M | $8.77M |
| Free Cash Flow | |||||
| Free Cash Flow | $0.00M | ($22.36M) | ($13.10M) | ($22.31M) | ($6.37M) |
| FCF Margin %(computed) | 0.00% | -758.47% | -429.73% | -384.98% | -418.77% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Heat Biologics, Inc.
关于Heat Biologics, Inc.（HTBX）现金流量表
Heat Biologics, Inc. 2021财年经营活动现金流$0.00B，自由现金流$0.00B（FCF利润率0.00%），资本支出$0.00B。
常见问题
HTBX · 4 问Heat Biologics, Inc. 2021财年自由现金流$0.00B，同比up100.0%。
HTBX free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10